Prosecution Insights
Last updated: April 19, 2026

Orna Therapeutics Inc.

4 pending office actions

Portfolio Summary

4
Total Pending OAs
2
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18697259 Lipid Nanoparticle Compositions for Delivering Circular Polynucleotides STEVENS, MARK V 1613 Non-Final OA Mar 29, 2024
18069621 CIRCULAR RNA COMPOSITIONS AND METHODS BURKHART, MICHAEL D 1638 Final Rejection Dec 21, 2022
17998219 CIRCULAR RNA COMPOSITIONS AND METHODS KENYON, JOHN S 1625 Non-Final OA Nov 08, 2022
17996074 CIRCULAR RNA COMPOSITIONS AND METHODS NOBLE, MARCIA STEPHENS 1632 Final Rejection Oct 12, 2022

Managing Orna Therapeutics Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month